| B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020 | 1674 | 2020 |
| Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ... Cell reports 23 (1), 239-254. e6, 2018 | 906 | 2018 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 698 | 2018 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 685 | 2018 |
| Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ... Nature medicine 24 (11), 1649-1654, 2018 | 685 | 2018 |
| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 370 | 2020 |
| iTALK: an R package to characterize and illustrate intercellular communication Y Wang, R Wang, S Zhang, S Song, C Jiang, G Han, M Wang, J Ajani, ... BioRxiv, 507871, 2019 | 207 | 2019 |
| Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma L Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ... Science translational medicine 11 (491), eaau1167, 2019 | 202 | 2019 |
| Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma R Wang, M Dang, K Harada, G Han, F Wang, M Pool Pizzi, M Zhao, ... Nature medicine 27 (1), 141-151, 2021 | 157 | 2021 |
| Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response R Wang, S Song, K Harada, FG Amlashi, B Badgwell, MP Pizzi, Y Xu, ... Gut 69 (1), 18-31, 2020 | 127 | 2020 |
| Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis E Del Poggetto, IL Ho, C Balestrieri, EY Yen, S Zhang, F Citron, R Shah, ... Science 373 (6561), eabj0486, 2021 | 120 | 2021 |
| 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, ... Nature communications 12 (1), 5606, 2021 | 98 | 2021 |
| Long‐term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib P Jain, R Kanagal‐Shamanna, S Zhang, M Ahmed, A Ghorab, L Zhang, ... British journal of haematology 183 (4), 578-587, 2018 | 98 | 2018 |
| Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer SM Reddy, A Reuben, S Barua, H Jiang, S Zhang, L Wang, ... Cancer immunology research 7 (6), 1025-1035, 2019 | 83 | 2019 |
| Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance Y Chu, E Dai, Y Li, G Han, G Pei, DR Ingram, K Thakkar, JJ Qin, M Dang, ... Nature medicine 29 (6), 1550-1562, 2023 | 64 | 2023 |
| Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL)‐outcomes and mutation profile from venetoclax resistant MCL patients S Zhao, R Kanagal‐Shamanna, L Navsaria, CY Ok, S Zhang, K Nomie, ... American journal of hematology 95 (6), 623-629, 2020 | 64 | 2020 |
| Patterns of genomic evolution in advanced melanoma E Birkeland, S Zhang, D Poduval, J Geisler, S Nakken, D Vodak, ... Nature communications 9 (1), 2665, 2018 | 57 | 2018 |
| Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL P Jain, S Zhang, R Kanagal-Shamanna, CY Ok, K Nomie, GN Gonzalez, ... Blood Advances 4 (6), 1038-1050, 2020 | 51 | 2020 |
| A genomic instability score in discriminating nonequivalent outcomes of BRCA1/2 mutations and in predicting outcomes of ovarian cancer treated with platinum-based chemotherapy S Zhang, Y Yuan, D Hao PloS one 9 (12), e113169, 2014 | 47 | 2014 |
| Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma S Zhang, VC Jiang, G Han, D Hao, J Lian, Y Liu, R Zhang, J McIntosh, ... Nature communications 12 (1), 2877, 2021 | 44 | 2021 |
Linghua WangAssociate Professor, Genomic Medicine, MD Anderson Cancer CenterVerified email at mdanderson.org
